Becton, dickinson and company launches enhanced antimicrobial stewardship analytics capabilities

Becton, dickinson and company announced its latest advancement in combating antimicrobial resistance (amr) with new analytics integrated into the company's connected medication management platform that identifies when an inappropriate and potentially ineffective antibiotic has been prescribed, based on a patient's specific infection diagnosis. bd healthsight clinical advisor is a new functionality within the bd healthsight connected medication management platform that aggregates disparate patient data to provide clinicians with the ability to receive near real-time medication stewardship alerts within the pharmacy workflow. these actionable alerts are delivered within the connected medication management process to help health care providers prevent not only the administration of inappropriate antibiotics, but also the potential waste of resources associated with compounding and preparing unnecessary medication for delivery. clinical stewardship programs are also supported through customized dashboards, robust reports and the ability to automate the submission of antimicrobial utilization data for regulatory reporting. these new integrated capabilities in the bd healthsight platform are the latest in bd infection surveillance technology. other bd infection surveillance offerings include data mining technology that creates an early warning system to detect infection anomalies before an outbreak occurs and tools for health care facilities to easily report infection data electronically to public health authorities for enhanced monitoring to identify local, regional and national trends.
BDX Ratings Summary
BDX Quant Ranking